[
  {
    "ts": null,
    "headline": "New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier",
    "summary": "Late-breaking research presented at the American Diabetes Association's 85th Scientific Sessions showed that Abbott's (NYSE: ABT) Healthy Food Rx \"food is medicine\" program helped people living with diabetes to eat better and feel healthier, with participants reporting improved diet quality and health status.",
    "url": "https://finnhub.io/api/news?id=a12597a608826ec1c5201d7166b6ea41540e402aff9e7dceb55d16b7da6cf6ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750462200,
      "headline": "New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier",
      "id": 135451031,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Late-breaking research presented at the American Diabetes Association's 85th Scientific Sessions showed that Abbott's (NYSE: ABT) Healthy Food Rx \"food is medicine\" program helped people living with diabetes to eat better and feel healthier, with participants reporting improved diet quality and health status.",
      "url": "https://finnhub.io/api/news?id=a12597a608826ec1c5201d7166b6ea41540e402aff9e7dceb55d16b7da6cf6ca"
    }
  },
  {
    "ts": null,
    "headline": "Top Research Reports for Meta Platforms, Palantir & Abbott",
    "summary": "META, PLTR, and ABT lead today's top research picks, with strong AI momentum, product innovation, and expanding market share.",
    "url": "https://finnhub.io/api/news?id=2e60bd063a41ba442b90bd8b359a26ca015c1fe6f055d1a076ccc9d4e6e86f8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750450800,
      "headline": "Top Research Reports for Meta Platforms, Palantir & Abbott",
      "id": 135445667,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "META, PLTR, and ABT lead today's top research picks, with strong AI momentum, product innovation, and expanding market share.",
      "url": "https://finnhub.io/api/news?id=2e60bd063a41ba442b90bd8b359a26ca015c1fe6f055d1a076ccc9d4e6e86f8c"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) Enhances Diabetes Care And Partners With Abu Dhabi For Pharma Expansion",
    "summary": "Recent events for Abbott Laboratories (NYSE:ABT) include the integration of Beta Bionics' iLet Bionic Pancreas with Abbott's sensor technology and a partnership with the Department of Health - Abu Dhabi, aiming to localize pharmaceutical manufacturing. Additional FDA approvals for key products and a declared dividend highlight the company's operational momentum. Despite these developments, the broader market impact included mixed U.S. stock performance and geopolitical tensions affecting...",
    "url": "https://finnhub.io/api/news?id=7260fe552a4a082c36e1202d1e6c4378e4b4f837850323bf4c74bddf6f14a653",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750440178,
      "headline": "Abbott Laboratories (NYSE:ABT) Enhances Diabetes Care And Partners With Abu Dhabi For Pharma Expansion",
      "id": 135443087,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Recent events for Abbott Laboratories (NYSE:ABT) include the integration of Beta Bionics' iLet Bionic Pancreas with Abbott's sensor technology and a partnership with the Department of Health - Abu Dhabi, aiming to localize pharmaceutical manufacturing. Additional FDA approvals for key products and a declared dividend highlight the company's operational momentum. Despite these developments, the broader market impact included mixed U.S. stock performance and geopolitical tensions affecting...",
      "url": "https://finnhub.io/api/news?id=7260fe552a4a082c36e1202d1e6c4378e4b4f837850323bf4c74bddf6f14a653"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories : 2024 GLOBAL SUSTAINABILITY REPORT",
    "summary": "GLOBAL SUSTAINABILITY REPORT 2024 ...",
    "url": "https://finnhub.io/api/news?id=cf18a0cbe055d3ecb14ff6f75d36579dcbfc37fa38126d097dd36671250b5fd1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750439585,
      "headline": "Abbott Laboratories : 2024 GLOBAL SUSTAINABILITY REPORT",
      "id": 135444114,
      "image": "",
      "related": "ABT",
      "source": "Finnhub",
      "summary": "GLOBAL SUSTAINABILITY REPORT 2024 ...",
      "url": "https://finnhub.io/api/news?id=cf18a0cbe055d3ecb14ff6f75d36579dcbfc37fa38126d097dd36671250b5fd1"
    }
  },
  {
    "ts": null,
    "headline": "DXCM's Access Gains and Operational Strength Offset Margin Pressures",
    "summary": "DXCM rides on record patient growth and T2D access gains, but margin pressure and FDA scrutiny cloud the outlook.",
    "url": "https://finnhub.io/api/news?id=6cf57b6ef94b2127591be8cdf61e2f7d11c04f938960668b434290022a40012c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750425900,
      "headline": "DXCM's Access Gains and Operational Strength Offset Margin Pressures",
      "id": 135440729,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "DXCM rides on record patient growth and T2D access gains, but margin pressure and FDA scrutiny cloud the outlook.",
      "url": "https://finnhub.io/api/news?id=6cf57b6ef94b2127591be8cdf61e2f7d11c04f938960668b434290022a40012c"
    }
  },
  {
    "ts": null,
    "headline": "Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States",
    "summary": "SAN DIEGO, June 20, 2025--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s FreeStyle Libre® 3 Plus continuous glucose monitoring (CGM) sensor. The Company has initiated an early access program in the United States (U.S.), and intends to scale availability in the second half of 2025.",
    "url": "https://finnhub.io/api/news?id=0541dbe870ee34842f323dad8552f83de73f731cc2d557d3ac45023db04da3a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750422600,
      "headline": "Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States",
      "id": 135440730,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "SAN DIEGO, June 20, 2025--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s FreeStyle Libre® 3 Plus continuous glucose monitoring (CGM) sensor. The Company has initiated an early access program in the United States (U.S.), and intends to scale availability in the second half of 2025.",
      "url": "https://finnhub.io/api/news?id=0541dbe870ee34842f323dad8552f83de73f731cc2d557d3ac45023db04da3a8"
    }
  },
  {
    "ts": null,
    "headline": "5 things to watch at the ADA’s Scientific Sessions",
    "summary": "The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for people with Type 2 diabetes and companies debut new devices.",
    "url": "https://finnhub.io/api/news?id=4747511ebdcc92f91f26daf19e81fdc523fed429b153f4a2e4454e71f95d62e8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750417562,
      "headline": "5 things to watch at the ADA’s Scientific Sessions",
      "id": 135440731,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for people with Type 2 diabetes and companies debut new devices.",
      "url": "https://finnhub.io/api/news?id=4747511ebdcc92f91f26daf19e81fdc523fed429b153f4a2e4454e71f95d62e8"
    }
  }
]